Fig. 7From: Identification of COPA as a potential prognostic biomarker and pharmacological intervention target of cervical cancer by quantitative proteomics and experimental verificationSurvival analysis of COPA in clinical samples. A Kaplan–Meier survival analysis for cervical cancer patients with different IHC staining for COPA (score 0-1vs score 2–3). B ROC curve analysis for cervical cancer patients with moderate (score 2) or strong (score 3) COPA stainingBack to article page